Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma

Journal of Clinical Gastroenterology

Volumn 47, Issue 10, 2013, Pages 861-870

  Meza Junco, Judith ^a   Montano Loza, Aldo J ^b   Baracos, Vickie E ^a   Prado, Carla M M ^c   Bain, Vincent G ^b   Beaumont, Crystal ^a   Esfandiari, Nina ^a   Lieffers, Jessica R ^a   Sawyer, Michael B ^a  

^a CROSS CANCER INSTITUTE   (Canada)

^b UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^c FLORIDA STATE UNIVERSITY   (United States)

Author keywords

complications; lumbar skeletal muscle index; muscle wasting; prognostic factor; scoring systems

Indexed keywords

SODIUM;

ADULT; ARTICLE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER GRAFT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUTRITIONAL STATUS; PRIORITY JOURNAL; SARCOPENIA; SKELETAL MUSCLE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NUTRITIONAL STATUS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SARCOPENIA; SURVIVAL ANALYSIS;

EID: 84886601040     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e318293a825     Document Type: Article

References (36)

1. Gish RG. Hepatocellular carcinoma: Overcoming challenges in disease management. Clin Gastroenterol Hepatol. 2006;4:252-261
2. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 2009;27:1485-1491
3. Schutte K, Bornschein J, Malfertheiner P. Hepatocellular carcinoma - Epidemiological trends and risk factors. Dig Dis. 2009;27:80-92
4. Bruix J, Llovet JM. Major achievements in hepatocellular carcinoma. Lancet. 2009;373:614-616
5. Bruix J, Sherman M. Management of hepatocellular carcinoma: An update. Hepatology. 2011;53:1020-1022
6. Sabel MS, Lee J, Cai S, et al. Sarcopenia as a prognostic factor among patients with stage III melanoma. Ann Surg Oncol. 2011;18:3579-3585
7. Landi F, Liperoti R, Fusco D, et al. Prevalence and risk factors of sarcopenia among nursing home older residents. J Gerontol A Biol Sci Med Sci. 2012;67:48-55
8. Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study. Lancet Oncol. 2008;9:629-635
9. Montano-Loza AJ, Meza-Junco J, Prado CM, et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol. 2012;10:166-173
10. Honda H, Qureshi AR, Axelsson J, et al. Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality. Am J Clin Nutr. 2007; 86:633-638
11. Roubenoff R, Hughes VA. Sarcopenia: Current concepts. J Gerontol A Biol Sci Med Sci. 2000;55:M716-M724
12. Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147:755-763
13. Lang T, Streeper T, Cawthon P, et al. Sarcopenia: Etiology, clinical consequences, intervention, and assessment. Osteoporos Int. 2010;21:543-559
14. Janssen I. Evolution of sarcopenia research. Appl Physiol Nutr Metab. 2010;35:707-712
15. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual. 7th ed. Springer: Tampa, FL; 2010
16. Mitsiopoulos N, Baumgartner RN, Heymsfield SB, et al. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol. 1998;85:115-122
17. Kvist H, Sjostrom L, Tylen U. Adipose tissue volume determinations in women by computed tomography: Technical considerations. Int J Obes. 1986;10:53-67
18. Vehmas T, Kairemo KJ, Taavitsainen MJ. Measuring visceral adipose tissue content from contrast enhanced computed tomography. Int J Obes Relat Metab Disord. 1996; 20:570-573
19. Mourtzakis M, Prado CM, Lieffers JR, et al. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab. 2008;33:997-1006
20. Martin L, Birdsell L, MacDonald N, et al. Cancer cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013, (In press
21. Heinze G, Gnant M, Schemper M. Exact log-rank tests for unequal follow-up. Biometrics. 2003;59:1151-1157
22. Gill R. Understanding Cox's regression model. Experientia Suppl. 1982;41:187-199
23. Hanley JAMB. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29-36
24. Alberino F, Gatta A, Amodio P, et al. Nutrition and survival in patients with liver cirrhosis. Nutrition. 2001;17:445-450
25. Gunsar F, Raimondo ML, Jones S, et al. Nutritional status and prognosis in cirrhotic patients. Aliment Pharmacol Ther. 2006;24:563-572
26. Fukushima K, Ueno Y, Kawagishi N, et al. The nutritional index 'CONUT' is useful for predicting long-term prognosis of patients with end-stage liver diseases. Tohoku J Exp Med. 2011;224:215-219
27. Fearon KC. Cancer cachexia and fat-muscle physiology. N Engl J Med. 2011;365:565-567
28. Prado CM, Baracos VE, McCargar LJ, et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res. 2009;15: 2920-2926
29. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on sarcopenia in older people. Age Ageing. 2010;39:412-423
30. Heymsfield SB. Development of imaging methods to assess adiposity and metabolism. Int J Obes (Lond). 2008;32(suppl 7): S76-S82
31. Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection. Hepatology. 2010;51:1820-1832
32. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557-2576
33. Kachaamy T, Bajaj JS, Heuman DM. Muscle and mortality in cirrhosis. Clin Gastroenterol Hepatol. 2012;10: 100-102
34. Forner A, Reig ME, de Lope CR, et al. Current strategy for staging and treatment: The BCLC update and future prospects. Semin Liver Dis. 2010;30:61-74
35. Parsons HA, Baracos VE, Dhillon N, et al. Body composition, symptoms, and survival in advanced cancer patients referred to a phase I service. PLoS One. 2012;7:e29330
36. Tan BH, Birdsell LA, Martin L, et al. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res. 2009;15:6973-6979